B.S. (Honors), University of Toronto, Toronto, Canada, 1973
M.D., Medical College of Virginia, Richmond, VA, 1977
Diabetes mellitus
Clinical Instructor, Medical College of Virginia, Richmond, VA, 1980-1984
Instructor in Medicine, Harvard Medical School, Boston, MA, 1984-1987
Assistant Professor, Department of Medicine, Harvard Medical School, Boston, MA, 1987-1992
Assistant Professor, Department of Medicine, Tufts University School of Medicine/New England Medical Center, Boston, MA, 1992-1994
Associate Professor, Department of Medicine, Tufts University School of Medicine/New England Medical Center, Boston, MA, 1994-1996
Associate Director (Acting Director 1/95-5/95), General Clinical Research Center, Tufts University School of Medicine/New England Medical Center, Boston, MA, 1994-1996
Acting Chief, Division of Endocrinology, Diabetes, Metabolism, and Molecular Medicine, New England Medical Center, Boston, MA, 1995-1996
Associate Professor, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, College of Medicine, University of Vermont, Burlington, VT, 1996-2000
Director, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, College of Medicine, University of Vermont, Burlington, VT, 1996-2010
Co-Director, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, College of Medicine, University of Vermont, Burlington, VT, 2011-2016
Professor, Department of Medicine, College of Medicine, University of Vermont, Burlington, VT, 2000-2020
Professor Emeritus, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, 2021-present
Young Investigator Award, American Diabetes Association, Virginia Affiliate, 1984
Research and Development Award, American Diabetes Association, 1985-1986
FIRST Award, National Institutes of Health, 1986-1991
Best Teacher, Joslin Diabetes Center, 1988
American Society of Clinical Investigation, 1995
Areteios Lecture, 5th Panhellenic Diabetological Congress, Athens Greece, 1997
Shafic Haddad Memorial Lecture, 32nd Middle East Medical Assembly, Beirut, Lebanon, 1997
Alpha Omega Alpha, 2002
Dr. Manuel Paniagua Memorial Lecture, Sociedad Puertorriquena de Endocrinologia y Diabetologia, Rio Grande, Puerto Rico, 2006
Gerald J and Dorothy R Friedman Lecture in Diabetes, Tufts Medical Center, Boston, MA, 2008
Sarah Nichols Gruenig Green & Gold Professor of Diabetes Research, Larner College of Medicine, University of Vermont, Burlington, VT 2015-2020
Delghingaro-Augusto V, Nolan CJ, Gupta D, Jetton TL, Latour MG, Peshavaria M, Murthy Madiraju SR, Joly É, Prentki M-L, Leahy J. Islet beta cell failure in the 60% pancreatectomized obese hyperlipidaemic Zucker fatty rat. Severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass. Diabetologia 2009; 52(6):1122-1132.
Leahy JL. Thiazolidinediones in prediabetes and early type 2 diabetes: What can be learned about that disease’s pathogenesis. Curr Diab Rep 2009; 9:215-220.
Gupta D, Peshavaria M, Monga N, Jetton TL, Leahy JL. Physiologic and pharmacologic modulation of glucose-dependent insulinotropic polypeptide (GIP) receptor expression in beta-cells by peroxisome proliferator-activated receptor (PPAR)-gamma signaling: Possible mechanism for the GIP resistance in type 2 diabetes. Diabetes 2010; 59:1445-1450.
Leahy JL, Hirsch IB, Peterson KA, Schneider D. Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus. J Clin Endocrinol Metab 2010; 95:4206-4216.
Leahy J, Pratley R. What is type 2 diabetes mellitus? Crucial role of maladaptive changes in beta cell and adipocyte biology. Translational Endocrinology and Metabolism 2011; 2:9-42.
For a complete list of Dr. Leahy's publications, please visit PubMed.